These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35874794)

  • 1. Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach.
    Ong AKS; Prasetyo YT; Lagura FC; Ramos RN; Salazar JML; Sigua KM; Villas JA; Chuenyindee T; Nadlifatin R; Persada SF; Thana K
    Public Health Pract (Oxf); 2022 Dec; 4():100300. PubMed ID: 35874794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Willingness to get Vaccinated Against SARS-CoV-2 Virus among Southeast Asian Countries: Does the Vaccine Brand Matter?
    Duong AH; Antriyandarti E
    Appl Res Qual Life; 2023; 18(2):765-793. PubMed ID: 36124083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
    Xiao J; Wang F; Wang M; Ma Z
    Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
    Mancuso M; Eikenberry SE; Gumel AB
    Infect Dis Model; 2021; 6():1110-1134. PubMed ID: 34518808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
    Merkley E; Loewen PJ
    Vaccine; 2022 Mar; 40(13):2020-2027. PubMed ID: 35216840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer Preference Analysis on Attributes of Milk Tea: A Conjoint Analysis Approach.
    Ong AKS; Prasetyo YT; Libiran MADC; Lontoc YMA; Lunaria JAV; Manalo AM; Miraja BA; Young MN; Chuenyindee T; Persada SF; Perwira Redi AAN
    Foods; 2021 Jun; 10(6):. PubMed ID: 34203864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.
    Tobaiqy M; MacLure K; Elkout H; Stewart D
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference analysis on the online learning attributes among senior high school students during the COVID-19 pandemic: A conjoint analysis approach.
    S Ong AK; Prasetyo YT; Chuenyindee T; Young MN; Doma BT; Caballes DG; Centeno RS; Morfe AS; Bautista CS
    Eval Program Plann; 2022 Jun; 92():102100. PubMed ID: 35487051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccine Perception in South Korea: Web Crawling Approach.
    Lee H; Noh EB; Park SJ; Nam HK; Lee TH; Lee GR; Nam EW
    JMIR Public Health Surveill; 2021 Sep; 7(9):e31409. PubMed ID: 34348890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
    Merkley E; Loewen PJ
    JAMA Netw Open; 2021 Sep; 4(9):e2126635. PubMed ID: 34591105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population.
    Camacho Moll ME; Salinas Martínez AM; Tovar Cisneros B; García Onofre JI; Navarrete Floriano G; Bermúdez de León M
    Front Public Health; 2022; 10():834744. PubMed ID: 35359754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality Effects on Chinese Public Preference for the COVID-19 Vaccination: Discrete Choice Experiment and Latent Profile Analysis Study.
    Zhang J; Ge P; Li X; Yin M; Wang Y; Ming W; Li J; Li P; Sun X; Wu Y
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457708
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines.
    Adjobimey T; Meyer J; Sollberg L; Bawolt M; Berens C; Kovačević P; Trudić A; Parcina M; Hoerauf A
    Front Immunol; 2022; 13():917905. PubMed ID: 35799790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson.
    Patel R; Kaki M; Potluri VS; Kahar P; Khanna D
    Hum Vaccin Immunother; 2022 Dec; 18(1):2002083. PubMed ID: 35130825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How important is the tuition fee during the COVID-19 pandemic in a developing country? Evaluation of filipinos' preferences on public university attributes using conjoint analysis.
    Belmonte ZJA; Prasetyo YT; Ong AKS; Chuenyindee T; Yuduang N; Kusonwattana P; Nadlifatin R; Persada SF; Buaphiban T
    Heliyon; 2022 Nov; 8(11):e11205. PubMed ID: 36284771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.